EX-4.2 3 d899078dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 ZOETIS INC. SEVENTH SUPPLEMENTAL INDENTURE Dated as of August 18, 2025 4.150% Senior Notes due 2028 5.000% Senior Notes due 2035 (Seventh Supplemental Indenture to the Indenture Dated as of January 28, 2013) DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.01 Certain Terms Defined in the Indenture; Additional Terms 2 Section 1.02 Definitions Incorporated into the Indenture 2 Section 1.03 Reserved. 7 ARTICLE II FORM AND TERMS OF THE NOTES 7 Section 2.01 Form and Dating 7 Section 2.02 Paying Agent; Depository 7 Section 2.03 Registration, Transfer and Exchange 8 Section 2.04 Reserved. …
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
ZOETIS INC.
ZTSNYSEEQUITYCurrent
Other Events
Item 8.01. Other Events. On August 11, 2025, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”), between the Company and the underwriters named therein, for the issuance and sale by the Company of $850,000,000 aggregate principal amount of its 4.150% Senior Notes due 2028 (the “2028 Notes”) and $1,000,000,000 aggregate principal amount of its 5.000% Senior Notes due…
Company context
Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com.
Current securities
Recent company filings
- 4 filingOct 13, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureOct 13, 2026
- Regulation FD DisclosureOct 8, 2026
- 4 filingAug 11, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 6, 2026
Disclosure sections
Item 8.01Item 8.01 - Other Events
Filed exhibits (3)
EX-4.3 4 d899078dex43.htm EX-4.3 EX-4.3 Exhibit 4.3 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. TRANSFERS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. ZOETIS INC. 4.150% S ENIOR N OTES DUE 2028 PRINCIPAL AMOUNT No. 1 $[•] CUSIP: 98978V AW3 ISIN: US98978VAW37 Zoetis Inc., a Delaware corporation (herein called the “Comp…
Open exhibit ↗EX-4.4 5 d899078dex44.htm EX-4.4 EX-4.4 Exhibit 4.4 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. TRANSFERS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. ZOETIS INC. 5.000% S ENIOR N OTES DUE 2035 PRINCIPAL AMOUNT No. 1 $[•] CUSIP: 98978V AX1 ISIN: US98978VAX10 Zoetis Inc., a Delaware corporation (herein call…
Open exhibit ↗